Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

552 studies match

clinicaltrialsPublishedShowing 101–150 of 552 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07288359	Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors	recruiting	Phase 1 / Phase 2	205	Novartis PharmaceuticalsINDUSTRY	10	Jul 30, 2026	clinicaltrials
NCT03075696	A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma	active not recruiting	Phase 1 / Phase 2	940	Hoffmann-La RocheINDUSTRY